Niguarda is at the forefront of research for trials testing new therapies supported by international cooperation activities.
In recent years a positive trend in clinical trial has been observed, in neuroscience, diabetology, pain therapy, gene therapy, cardiovascular diseases, haematology, oncology, resulting in an improved scientific impact factor.

Niguarda is a public hospital dedicated to care; clinical research and knowledge-sharing are fully integrated in the hospital strategy.

The presence of professional skills, technological competences, certified laboratories and high complexity patient cohorts make Niguarda a unique and interesting partner for future cooperation.

It offers concrete opportunities to Pharma and Biotech Companies that are looking for a reliable and expert clinical/scientific partner.

The attitude to a real multidisciplinary approach offered to researcher makes Niguarda as a unique “one stop shop” for research and development.

The main strength point is the high volume of diagnostic/therapeutic activities that allows
an optimal integration between research and patient care, defining Niguarda as one of the best possible clinical sites for translational research.


ASST Grande Ospedale Metropolitano Niguarda
Piazza Ospedale Maggiore, 3
20162 Milano - Italy